The Centers for Medicare & Medicaid Services (CMS) propose policy changes to payment for MA and Part D drug programs for 2023 and seek public comment. CMS also requests input on including a quality measure in MA and Part D Star Ratings that would assess how often plans are screening for common health-related social needs, such as food insecurity, housing insecurity, and transportation problems and what impact proposed payment changes for enrollees with end stage renal disease would have on rural and urban underserved populations.
Click here: Comments Requested: Medicare Advantage (MA) and Part D Advance Notice to provide comments. Comments are due on March 4.